The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases

The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases

Chronic insomnia is associated with cardiometabolic diseases. Here, in two clinical cohorts (n = 7,931), authors show that gut microbiota-bile acid axis may be an intervention target to attenuate the impact of chronic insomnia on cardiometabolic health.

Bibliographic Details
Main Authors:	Zengliang Jiang, Lai-bao Zhuo, Yan He, Yuanqing Fu, Luqi Shen, Fengzhe Xu, Wanglong Gou, Zelei Miao, Menglei Shuai, Yuhui Liang, Congmei Xiao, Xinxiu Liang, Yunyi Tian, Jiali Wang, Jun Tang, Kui Deng, Hongwei Zhou, Yu-ming Chen, Ju-Sheng Zheng
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-05-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-022-30712-x

Similar Items

Multi-omics analyses reveal relationships among dairy consumption, gut microbiota and cardiometabolic health
by: Menglei Shuai, et al.
Published: (2021-04-01)

Comparison of fecal and blood metabolome reveals inconsistent associations of the gut microbiota with cardiometabolic diseases
by: Kui Deng, et al.
Published: (2023-02-01)

Gut microbiota signatures of long-term and short-term plant-based dietary pattern and cardiometabolic health: a prospective cohort study
by: Zelei Miao, et al.
Published: (2022-06-01)

Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies
by: Zengliang Jiang, et al.
Published: (2020-12-01)

Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility
by: Fengzhe Xu, et al.
Published: (2023-02-01)

Human Gut Antibiotic Resistome and Progression of Diabetes
by: Menglei Shuai, et al.
Published: (2022-04-01)

Diet-gut microbiome interaction and its impact on host blood glucose homeostasis: a series of nutritional n-of-1 trialsResearch in context
by: Yuanqing Fu, et al.
Published: (2025-01-01)

Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
by: Yuanqing Fu, et al.
Published: (2021-07-01)

Does insomnia worsen cardiometabolic health?
by: Gewei Zhu, et al.
Published: (2019-02-01)

Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis
by: Xinxiu Liang, et al.
Published: (2022-11-01)

Bile Acids in the Treatment of Cardiometabolic Diseases
by: Libor Vítek
Published: (2017-11-01)

Temporal relationship among adiposity, gut microbiota, and insulin resistance in a longitudinal human cohort
by: Kui Deng, et al.
Published: (2022-05-01)

Insomnia and circadian misalignment: an underexplored interaction towards cardiometabolic risk
by: Barbara Nobre, et al.
Published: (2021-03-01)

The Circadian Axis and Cardiometabolic Syndrome
by: Varga Boglárka, et al.
Published: (2022-09-01)

Integration of an interpretable machine learning algorithm to identify early life risk factors of childhood obesity among preterm infants: a prospective birth cohort
by: Yuanqing Fu, et al.
Published: (2020-07-01)

The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
by: Cengiz Callender, et al.
Published: (2022-01-01)

Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases
by: Baoyi Guan, et al.
Published: (2022-05-01)

Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions
by: Paul M. Ryan, et al.
Published: (2017-12-01)

Early-life exposure to the Great Chinese Famine and gut microbiome disruption across adulthood for type 2 diabetes: three population-based cohort studies
by: Wanglong Gou, et al.
Published: (2023-11-01)

The role of bile acid in intestinal metaplasia
by: Menglei Wang, et al.
Published: (2023-02-01)

Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
by: Fangfang Zeng, et al.
Published: (2024-03-01)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
by: Yu-Lin Zhang, et al.
Published: (2022-09-01)

Dynamics of the Gut Bacteria and Fungi Accompanying Low-Carbohydrate Diet-Induced Weight Loss in Overweight and Obese Adults
by: Dan Yu, et al.
Published: (2022-02-01)

Interactions between Insomnia, Sleep Disordered Breathing and Cardiometabolic Risk in Patients Complaining of Pain in the Orofacial Region
by: Miguel Meira e Cruz, et al.
Published: (2025-01-01)

The oral-gut microbiota axis: a link in cardiometabolic diseases
by: Qian Xu, et al.
Published: (2025-01-01)

The gut microbiota-bile acid axis in cholestatic liver disease
by: Dayan sun, et al.
Published: (2024-07-01)

Westlake Gut Project: A consortium of microbiome epidemiology for the gut microbiome and health research in China
by: Wanglong Gou, et al.
Published: (2022-12-01)

Genetically Predicted Insomnia in Relation to 14 Cardiovascular Conditions and 17 Cardiometabolic Risk Factors: A Mendelian Randomization Study
by: Xinhui Liu, et al.
Published: (2021-08-01)

Two-week continuous glucose monitoring-derived metrics and degree of hepatic steatosis: a cross-sectional study among Chinese middle-aged and elderly participants
by: Haili Zhong, et al.
Published: (2024-08-01)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
by: Yiming Ni, et al.
Published: (2022-06-01)

Mapping the gut microecological multi-omics signatures to serum metabolome and their impact on cardiometabolic health in elderly adultsResearch in context
by: Chu-wen Ling, et al.
Published: (2024-07-01)

Exploring the pathogenesis of insomnia and acupuncture intervention strategies based on the microbiota-gut-brain axis
by: Jia Guo, et al.
Published: (2024-09-01)

Objective short sleep duration is associated with the activity of the hypothalamic-pituitary-adrenal axis in insomnia
by: Carolina D’Aurea, et al.
Published: (2015-06-01)

Multiagonists of the “incretin axis” as a promising tool for managing cardiometabolic risk in visceral obesity
by: M. A. Druzhilov, et al.
Published: (2022-05-01)

Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
by: Yinping Pan, et al.
Published: (2024-12-01)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
by: Rui Xue, et al.
Published: (2021-10-01)

Streptozotocin – induced diabetes, bile-pancreatic secretion and insulo-pancreon-axis interaction
by: Osvaldo Manuel Tiscornia, et al.
Published: (2013-01-01)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
by: Lingfeng Li, et al.
Published: (2022-09-01)

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
by: Meilin Wei, et al.
Published: (2020-05-01)

Insomnia in Pregnancy and Factors Related to Insomnia
by: Aynur Kızılırmak, et al.
Published: (2012-01-01)